Autonomous Res Predicts Equifax FY2025 Earnings

Equifax, Inc. (NYSE:EFXFree Report) – Analysts at Autonomous Res issued their FY2025 EPS estimates for Equifax in a research report issued to clients and investors on Tuesday, January 27th. Autonomous Res analyst K. Zhu anticipates that the credit services provider will post earnings of $7.64 per share for the year. The consensus estimate for Equifax’s current full-year earnings is $7.58 per share. Autonomous Res also issued estimates for Equifax’s Q4 2025 earnings at $2.07 EPS and FY2028 earnings at $21.63 EPS.

Several other equities analysts also recently commented on the company. Morgan Stanley decreased their target price on Equifax from $290.00 to $280.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 17th. Wells Fargo & Company decreased their price objective on Equifax from $285.00 to $265.00 and set an “overweight” rating on the stock in a report on Wednesday, January 14th. Oppenheimer lowered their price objective on Equifax from $271.00 to $266.00 and set an “outperform” rating on the stock in a research report on Monday, January 12th. Needham & Company LLC reissued a “buy” rating and set a $295.00 target price on shares of Equifax in a report on Tuesday, October 21st. Finally, Bank of America decreased their price target on shares of Equifax from $285.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 3rd. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $271.14.

View Our Latest Analysis on Equifax

Equifax Stock Down 0.7%

Equifax stock opened at $203.89 on Thursday. The company’s 50-day moving average price is $215.46 and its two-hundred day moving average price is $230.50. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.82. The stock has a market cap of $24.95 billion, a P/E ratio of 38.69, a P/E/G ratio of 2.08 and a beta of 1.56. Equifax has a twelve month low of $199.98 and a twelve month high of $281.03.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its stake in Equifax by 49.2% during the fourth quarter. Brighton Jones LLC now owns 3,638 shares of the credit services provider’s stock worth $927,000 after purchasing an additional 1,200 shares during the last quarter. Great Lakes Advisors LLC bought a new stake in shares of Equifax during the 1st quarter worth $204,000. Empowered Funds LLC lifted its position in shares of Equifax by 14.6% during the 1st quarter. Empowered Funds LLC now owns 2,523 shares of the credit services provider’s stock worth $615,000 after buying an additional 321 shares during the last quarter. Farther Finance Advisors LLC boosted its stake in Equifax by 15.1% in the second quarter. Farther Finance Advisors LLC now owns 610 shares of the credit services provider’s stock valued at $158,000 after buying an additional 80 shares in the last quarter. Finally, Perigon Wealth Management LLC bought a new position in Equifax in the second quarter valued at about $209,000. 96.20% of the stock is owned by institutional investors.

Equifax Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Monday, November 24th were given a $0.50 dividend. The ex-dividend date was Monday, November 24th. This represents a $2.00 annualized dividend and a dividend yield of 1.0%. Equifax’s payout ratio is presently 37.95%.

Key Equifax News

Here are the key news stories impacting Equifax this week:

  • Positive Sentiment: Autonomous Research published a wide-ranging set of EPS forecasts that are substantially above current consensus for FY2026–FY2028 (FY2026: $8.57, FY2027: $10.32, FY2028: $21.63), signalling strong long-term revenue/profit upside in their model — this can support the stock if results/guide trend toward those levels.
  • Positive Sentiment: Equifax launched two Employment Insights solutions for auto dealers that integrate verified employment/income data with the consumer credit report; this product extension targets earlier-stage auto lending decisions and could drive incremental revenue and deeper data monetization. Equifax Launches Employment Insights Solutions for Auto Dealers
  • Neutral Sentiment: A Zacks piece compares Equifax (EFX) with Hackett Group (HCKT) for value investors — useful context for relative valuation decisions but not an immediate catalyst. HCKT or EFX: Which Is the Better Value Stock Right Now?
  • Negative Sentiment: Another Zacks preview warns Equifax may report a near-term earnings decline and lacks the apparent setup for an earnings beat in the upcoming report; that expectation is a likely driver of short-term selling pressure ahead of results. Analysts Estimate Equifax (EFX) to Report a Decline in Earnings: What to Look Out for

Equifax Company Profile

(Get Free Report)

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.

See Also

Earnings History and Estimates for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.